Stock Scorecard



Stock Summary for Grifols SA (GRFS) - $7.27 as of 3/31/2025 4:06:33 PM EST

Total Score

13 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for GRFS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GRFS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GRFS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for GRFS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for GRFS (39 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 6
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 5
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for GRFS

Blood Collection Devices Market Size to Reach US$ 14.02 Billion by 2030, Driven by Technological Innovations and Rising Demand for Minimally Invasive Diagnostics by The Insight Partners 3/21/2025 11:56:00 AM
Will ADMA Biologics Stock Continue Its Momentum in 2025? 3/14/2025 1:40:00 PM
Molecular Infectious Disease Testing Market to Hit US$17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™. 3/5/2025 12:30:00 PM
Bleeding Disorder Treatment Market to Reach USD 35 Billion by 2035, Growing at 7.3% CAGR | Fact.MR Report 3/5/2025 12:00:00 PM
Should You Add RIGL Stock to Your Portfolio Pre-Q4 Earnings? 2/25/2025 6:41:00 PM
ADMA Loses 8.9% in a Month: How Should You Play the Stock? 2/7/2025 6:41:00 PM
Last men standing: The short sellers left after Hindenburg's exit 1/28/2025 5:00:00 AM
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? 1/10/2025 6:41:00 PM
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip? 12/10/2024 6:13:00 PM
Parenteral Nutrition Market to Surpass Valuation of USD 12,324.1 Million by 2031 | SkyQuest Technology 12/6/2024 1:00:00 AM

Financial Details for GRFS

Company Overview

Ticker GRFS
Company Name Grifols SA
Country USA
Description Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2024
Next Earnings Date 5/12/2025

Stock Price History

Last Day Price 7.27
Price 4 Years Ago 11.23
Last Day Price Updated 3/31/2025 4:06:33 PM EST
Last Day Volume 586,558
Average Daily Volume 1,224,422
52-Week High 9.96
52-Week Low 5.79
Last Price to 52 Week Low 25.56%

Valuation Measures

Trailing PE 35.00
Industry PE 37.01
Sector PE 40.10
5-Year Average PE 22.29
Free Cash Flow Ratio 2.90
Industry Free Cash Flow Ratio 11.91
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 2.26
Total Cash Per Share 2.51
Book Value Per Share Most Recent Quarter 7.87
Price to Book Ratio 0.80
Industry Price to Book Ratio 8.86
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 0.83
Industry Price to Sales Ratio Twelve Trailing Months 88.85
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 257,444,000
Market Capitalization 1,871,617,880
Institutional Ownership N/A

Dividends

Ex-Dividend Date 6/3/2021
Previous Dividend Amount 0.0000
Current Dividend Amount 0.4566
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 1.07
Forward Annual Dividend Yield 14.29%
5-Year Dividend Payments Count 2
3-Year Average Dividend Yield 4.07%
5-Year Average Dividend Yield 2.29%
1-Year Dividend Growth Rate Percentage 100.00%
3-Year Dividend Growth Rate Percentage 112.91%
5-Year Dividend Growth Rate Percentage 17.53%
All-Time Dividend Growth Rate Percentage 16.22%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -66.70%
Annual Earnings Growth -71.52%
Reported EPS 12 Trailing Months 0.26
Reported EPS Past Year 0.50
Reported EPS Prior Year 0.46
Net Income Twelve Trailing Months 143,944,000
Net Income Past Year 59,315,000
Net Income Prior Year 208,279,000
Quarterly Revenue Growth YOY 12.20%
5-Year Revenue Growth 8.00%
Operating Margin Twelve Trailing Months 20.10%

Balance Sheet

Total Cash Most Recent Quarter 644,942,000
Total Cash Past Year 529,577,000
Total Cash Prior Year 547,979,000
Net Cash Position Most Recent Quarter -6,293,508,000
Net Cash Position Past Year -7,685,720,000
Long Term Debt Past Year 8,215,297,000
Long Term Debt Prior Year 8,154,264,000
Total Debt Most Recent Quarter 6,938,450,000
Equity to Debt Ratio Past Year 0.41
Equity to Debt Ratio Most Recent Quarter 0.44
Total Stockholder Equity Past Year 5,827,166,000
Total Stockholder Equity Prior Year 6,129,938,000
Total Stockholder Equity Most Recent Quarter 5,349,895,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 288,040,000
Free Cash Flow Per Share Twelve Trailing Months 1.12
Free Cash Flow Past Year -87,137,000
Free Cash Flow Prior Year -386,427,000

Options

Put/Call Ratio 5.76
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.05
MACD Signal 0.05
20-Day Bollinger Lower Band 6.40
20-Day Bollinger Middle Band 7.66
20-Day Bollinger Upper Band 8.93
Beta 0.69
RSI 38.82
50-Day SMA 7.78
150-Day SMA 8.49
200-Day SMA 9.68

System

Modified 3/27/2025 9:46:38 PM EST